Sign in
4

Changes in Ownership

NEKTAR THERAPEUTICS Filed Acc 0001209191-18-011597

President & CEO sold 12,788 shares at $82.94 ($1,060,637)

From the SEC's structured data for this filing

Trades in this filing

Insider Date Transaction Shares Price Value Owned after D/I In the form
ROBIN HOWARD W President & CEO 2018-02-16 Sale −12,788 $82.94 $1,060,637 237,147 D
Open-market sales · 12,788 sh · avg $82.94 · $1,060,637
Loading xslF345X03/doc4.xml…